Toggle Dropdown
Announcements
Projects
Welcome guest
Log in
Loading
Loading...
https://www.timesofisrael.com/novel-alzheimers-drug-gets-full-fda-approval-though-efficacy-and-risk-questioned/
0
0
Novel Alzheimer’s drug gets full FDA approval, though efficacy and risk questioned - The Times of Israel
7/8/23 at 4:32pm
Organization
The Times of Israel
Authors
Details
37 words
Summarize
Drugs & Medications
Neurological Conditions
general
The Times of Israel Leqembi
Novel Alzheimer's
FDA
note dangers
Leqembi is first medicine convincingly shown to modestly slow cognitive decline, but some experts say effect too subtle, note dangers
Show more
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...